Market Overview

Novabay Announces Neutrophase Available in Spray Pump


NovaBay Pharmaceuticals (NYSE: NBY) today announced that it has received 510k clearance from the Food and Drug Administration to market NeutroPhase® Skin and Wound Cleanser under widened indications including the moistening and debriding of graft and donor sites. Concurrently, the FDA cleared NeutroPhase to be administered through a new convenient spray pump.

Posted-In: News FDA


Related Articles (NBY)

View Comments and Join the Discussion!